Grant
Glycopeptide compositions
Applicants
- Xellia (Denmark)
[NORA names: Xellia; Private Research]
Abstract
Solutions comprising a glycopeptide antibiotic, e.g. vancomycin, and an amino acid or amino acid derivative, e.g. N-acetyl-glycine or N-acetyl-D-alanine, are provided. These solutions are stable or stabilized for long periods of time under normal conditions of use and storage, and can be formulated as pharmaceutical solutions for use in a subject. Methods of making and using these solutions are also provided, such as methods of stabilizing a glycopeptide antibiotic, e.g., vancomycin, with an amino acid or amino acid derivative, such as N-acetyl-glycine or N-acetyl-D-alanine.
Patent Family Records (67)
USE OF A COMPOSITION AND AN EXCIPIENT, PHARMACEUTICAL COMPOSITION, AND, METHODS OF STABILIZING AN ANTIBIOTIC AND MANUFACTURING A STABLE AQUEOUS PHARMACEUTICAL SOLUTION
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, PINDRIC KATARINA, KESER SABINA
2024, BR-112017009405-B1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, US-20230158101-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, US-11628200-B2
Glycopeptide compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, NZ-731955-A
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, KR-20230096142-A
GLYCOPEPTIDE COMPOSITIONS
셀리아 파마슈티칼즈 에이피에스 ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2023, KR-102603756-B1
GLYCOPEPTIDE COMPOSITIONS IN SOLUTION
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2023, EP-4147710-A1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, US-20220354927-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, US-11517609-B2
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2022, JP-7032488-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, HR-P20210342-T8
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2022, CY-1124011-T1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, US-20210220433-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, US-11000567-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, SI-3542812-T1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, RS-61418-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark)
2021, PT-3542812-T
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, PL-3542812-T3
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, HU-E053347-T2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, HR-P20210342-T1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, ES-2852550-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, EP-3834837-A1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2021, EP-3542812-B1
GLYCOPEPTIME COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2021, DK-3542812-T3
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KESER SABINA, PINDRIC KATARINA, JASPRICA IVONA
2021, CY-1122960-T1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS Yvonne Aspritsa, Sabine Keser, Katharina Pindyck
2021, CN-107073072-B
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, US-20200069768-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, US-10849956-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, SI-3215173-T1
ANTIBIOTIC COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2020, SA-517381446-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, RS-59851-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark)
2020, PT-3215173-T
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, PL-3215173-T3
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2020, JP-6797795-B2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2020, JP-2020183424-A
Glycopeptide compositions
IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2020, IL-252120-B
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, HU-E049857-T2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, HR-P20200101-T1
Glycopeptide Compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, ES-2769849-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EP-3215173-B8
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EP-3215173-B1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2020, EA-035368-B1
GLYCOPEPTIME COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) PINDRIC KATARINA, JASPRICA IVONA, KESER SABINA
2020, DK-3215173-T3
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, US-20190160142-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, US-10188697-B2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, EP-3542812-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2019, AU-2015341763-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, Sabina KESER, IVONA JASPRICA
2018, ZA-201702767-B
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, US-20180133286-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, US-10039804-B2
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, TN-2017000182-A1
GLYCOPEPTIDE COMPOSITIONS.
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) KATARINA PINDRIC, IVONA JASPRICA, Sabina KESER
2018, MX-2017005749-A
ANTIBIOTIC COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2018, CR-20170234-A
antibiotic compositions.
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER
2018, BR-112017009405-A2
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS, Zellia Pharmaceuticals Aps JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, US-20170348385-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, SG-11201703568W-A
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, PH-12017500720-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, KR-20170078830-A
Glycopeptide composition
Xellia (Denmark), Xellia Pharmaceuticals ApS ケセル、サビナ, ピンドリッチ、カタリーナ, ヤスプリカ、イノヴィア, (...more)
2017, JP-2017533218-A
Glycopeptide compositions
IVONA JASPRICA, KATARINA PINDRIC, Sabina KESER, XELLIA PHARMACEUTICALS APS, Xellia (Denmark) IVONA JASPRICA, Sabina KESER, KATARINA PINDRIC
2017, IL-252120-A0
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, EP-3215173-A1
Antibiotic compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CO-2017005391-A2
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CN-107073072-A
Antibiotic compositions
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, CL-2017001139-A1
Glycopeptide compositions
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2017, AU-2015341763-A1
GLYCOPEPTIDE COMPOSITIONS
XELLIA PHARMACEUTICALS APS, Xellia (Denmark) JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2016, WO-2016071495-A1
GLYCOPEPTIDE COMPOSITIONS
Xellia (Denmark), Xellia Pharmaceuticals ApS JASPRICA IVONA, KESER SABINA, PINDRIC KATARINA
2016, CA-2964524-A1